vaccine production News
-
AJ Vaccines expands capacity with a comprehensive reconstruction and renovation of its Polio vaccine production
AJ Vaccines has initiated a total reconstruction and expansion of its existing Polio vaccine production facilities. The new facilities will increase production capacity substantially while simultaneously ensuring compliance with future WHO demands for Polio vaccine production and containment. AJ Vaccines and the company’s owner have decided to initiate a comprehensive and needed upgrade of ...
-
Cell Bank Size and Demand in Commercial Vaccine Production
A common question of our clients is related to the size of a Cell Bank that is needed for future commercial manufacturing. How many vials of Master Cell Bank (MCB) and Working Cell Bank (WCB) do I need? Is this number sufficient for later production needs? Mammalian cell lines including Vero cells are generally amenable to cryopreservation, and this makes it possible to prepare reliable ...
By Nuvonis
-
We are looking for a Clinical Project Manager
Join us when we are expanding our unit with another Clinical Project Manager. In this role, you will lead the planning, execution and documentation of clinical studies for our late clinical phase vaccine products. Join us in our work to give people worldwide a longer and better life. We are an entrepreneurial company and experts in global vaccine development, manufacturing, registration and ...
-
Time critical delivery of biowaste decontamination systems completed at UK COVID-19 vaccine production facility
Suncombe has designed, built and delivered high specification biowaste effluent decontamination systems (EDS) in an extremely short timeframe to support the expanding Covid-19 vaccine production programme of a global manufacturer in the United Kingdom. To complete this work the company has constructed new vaccine production areas, each of which required a dedicated decontamination system for BSL3 ...
By Suncombe Ltd
-
EnviroChemie wins order for wastewater deactivation and detoxification from major vaccine producer
The wastewater from vaccine production at a world-leading pharmaceutical company will be safely deactivated and processed before being released into the sewer system. Plant constructor EnviroChemie has won the order for the planning, construction and commissioning of two wastewater processing plants for the production wastewater from a Benelux pharmaceutical company. The expansion of the ...
-
Enesi Pharma to Present at World Vaccine Congress 2021 Virtual Meeting
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces that its CEO, David Hipkiss will give a presentation at the upcoming World Vaccine Congress 2021 Virtual meeting (4-6 May 2021), which this year is free to attend. ...
-
ARTES receives Renewal of French Research Tax Credit (CIR) Accreditation
ARTES Biotechnology GmbH today announced that it has just obtained a renewal of governmental approval for ‘Crédit d’Impôt Recherche’ (CIR) for a next three-year period from the French Ministry of Higher Education and Research (MESR). The French R&D tax credit CIR gives French companies the ability to claim tax relief on 30% on all generated costs outsourced to ...
-
METTER TOLEDO measurement system provides inertization control in vaccine production
DATELINE -- During the vaccine production process, dissolved and gaseous oxygen measurement is critical to optimize the gas intertization phase. To help pharmaceutical manufacturers meet this need, METTLER TOLEDO offers a solution that combines its InPro6800 dissolved/gaseous oxygen sensors with its M300 two-channel multi-parameter transmitter. This system measures gaseous and dissolved oxygen ...
-
AJ Vaccines intend to widen activities in the Middle East Region
AJ Vaccines’ production site-facility in Copenhagen, Denmark has been approved by the Gulf Health Council (GHC) effective 9 November 2020. The approval indicates the vaccine production is at a high standard which will help to secure timely patient access to vaccines in the Gulf Cooperation Council (GCC) countries and wider Middle Eastern region. In recent years, the regulatory requirements ...
-
Enesi Pharma Enters Agreement with National Institutes of Health to Evaluate ImplaVax-enabled Flu Vaccines
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens, enabled by its ImplaVax® technologies, has entered into an agreement with the US National Institute of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to test a novel ...
-
Alfa Chemistry-A New Supplier of Vaccine Excipients, Nucleic Acid Delivery Excipients and SARS-CoV-2 Detection Raw Materials
Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging. “Always bearing in mind that what customers truly need is the top ...
-
(Viral) Vaccine Manufacturing
It is well accepted that vaccination is one of the most effective ways to prevent diseases. A vaccine helps the body’s immune system to recognize and fight pathogens like bacteria or viruses, which then keeps humans safe from the diseases they cause. Vaccines protect against a range of diseases, including measles, polio, diphtheria, tetanus, meningitis, influenza and cancer. ...
By Nuvonis
-
Alfa Chemistry Excels in mRNA Vaccine Development, Production, Optimization, and Quality Control
In the face of global health crises such as the COVID-19 pandemic, the development and production of vaccines have become paramount to safeguarding public health and restoring normalcy. Among the various vaccine technologies, mRNA vaccines have emerged as a groundbreaking solution, offering promising results in the fight against infectious diseases. Alfa Chemistry, a renowned scientific research ...
-
BlueWillow Biologics Names Leading Viral Infectious Disease Experts to Scientific Advisory Board
BlueWillow Biologics, Inc., a privately held clinical-stage biopharmaceutical company developing intranasal vaccines, today announced the formation of the Company’s Scientific Advisory Board (SAB) with three leading viral infectious disease experts. The SAB will provide strategic and scientific counsel to BlueWillow’s clinical programs. The members of the BlueWillow Biologics SAB ...
-
Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax-Enabled Pandemic Influenza Vaccine
Innovative needle-free injectable unit solid-dose presentation of recombinant H7N9 pandemic flu vaccine, created using Enesi’s ImplaVax technology, generated immune responses comparable with liquid vaccine and demonstrated excellent thermal stability at temperatures up to 40°C for six months. Enesi Pharma (“Enesi”), an innovative biotechnology company developing ...
-
Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine
International vaccine manufacturer, AJ Vaccines has received WHO prequalification for Picovax®, the first stand-alone dose sparing Inactivated Polio Vaccine (IPV) on 21st April 2020. First deliveries to UN agencies such as UNICEF and PAHO are expected by mid-2020. COPENHAGEN, 22 April 2020 – Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with ...
-
The biotechnology company Zendal launches a subsidiary exclusively for probiotics
The Galician biotechnology group Zendal, known as CZ-Biofabri until the end of last year, has just announced the launch of a new subsidiary called Zinereo Pharma, which will focus entirely on the manufacturing of probiotics. This new company was created after Biofabri split up into two companies specialized in human health: Biofabri, specialized in vaccine development and manufacturing, and the ...
-
Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella. ...
-
Enesi Pharma appoints Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations
Enesi Pharma Ltd (“Enesi”), an innovative biotechnology company developing next-generation vaccination products, targeting infectious diseases and emergent threat pathogens, enabled by its world leading ImplaVax® technologies, is delighted to announce the appointment of Elizabeth Eagling-Vose, MBA, as Senior Vice President, Operations. Ms. Eagling-Vose brings over 20 years’ ...
-
Enesi Pharma’s ImplaVax-Enabled, Solid-Dose Recombinant Classical Swine Fever (CSF) Vaccine Produces Immune Responses Superior to Liquid Vaccine
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, is delighted to report positive top-line results from a new study evaluating the immune responses generated by an ImplaVax®-enabled unit solid-dose formulation of classical ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you